SMTL ID : 7kk3.3 (3 other biounits)

Structure of the catalytic domain of PARP1 in complex with talazoparib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.06 Å

Oligo State

monomer

Ligands

1 x 2YQ: (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one(Non-covalent)

2YQ.1: 14 residues within 4Å: Chain A: Q.100, E.104, W.202, H.203, G.204, G.229, Y.230, Y.237, F.238, A.239, K.244, S.245, Y.248, E.329 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Y.230, A:Y.248, A:E.329 Hydrogen bonds: A:G.204, A:G.204 pi-Stacking: A:Y.248

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ryan, K. et al., Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1. J.Biol.Chem. (2021)

Release Date

2021-01-06

Peptides

Poly [ADP-ribose] polymerase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Poly [ADP-ribose] polymerase 1

Related Entries With Identical Sequence